Alexza Pharmaceuticals Inc.: 10-Q filed 2012-08-08
What Alexza Pharmaceuticals Inc. reported in its quarterly report filed 2012-08-08 (fiscal Q2 2012): 25 published measures, 74 facts as tagged in accession 0001193125-12-344097.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-08-08
- Fiscal period
- fiscal Q2 2012
- Accession
- 0001193125-12-344097 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Alexza Pharmaceuticals Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 45,385,000 | USD | |
| At 2011-12-31 | 48,605,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 3,322,000 | USD | |
| At 2011-12-31 | -9,692,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 18,526,000 | USD | |
| At 2011-12-31 | 14,902,000 | USD | |
| At 2011-06-30 | 15,872,000 | USD | |
| At 2010-12-31 | 13,671,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -6,957,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -10,784,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | -378,985,000 | USD | 4212 |
| 2011-04-01 to 2011-06-30 | -9,006,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -17,421,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -4,726,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | -268,370,000 | USD | 4212 |
| 2011-01-01 to 2011-06-30 | -15,938,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 29,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | 51,049,000 | USD | 4212 |
| 2011-01-01 to 2011-06-30 | 242,000 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 728,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,612,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | 68,093,000 | USD | 4212 |
| 2011-04-01 to 2011-06-30 | 1,258,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 2,517,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 5,960,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | 342,784,000 | USD | 4212 |
| 2011-01-01 to 2011-06-30 | 13,516,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 2,390,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | -55,888,000 | USD | 4212 |
| 2011-01-01 to 2011-06-30 | 4,623,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 17,875,000 | USD | |
| At 2011-12-31 | 20,425,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 2,016,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | 26,281,000 | USD | 4212 |
| 2011-01-01 to 2011-06-30 | 823,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -7,186,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -11,579,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | -362,178,000 | USD | 4212 |
| 2011-04-01 to 2011-06-30 | -8,141,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -15,964,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 26,895,000 | USD | |
| At 2011-12-31 | 27,552,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 380,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 813,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | 8,682,000 | USD | 4212 |
| 2011-04-01 to 2011-06-30 | 572,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 1,174,000 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 21,216,000 | USD | |
| At 2011-12-31 | 34,948,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 1,384,000 | USD | |
| At 2011-12-31 | 3,603,000 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2000-12-19 to 2012-06-30 | 8,000 | USD | 4212 |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 9,689,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 615,000 | USD | |
| At 2011-12-31 | 628,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-06-30 | 522,000 | USD | |
| At 2011-12-31 | 649,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | -6,957,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -10,784,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | -362,508,000 | USD | 4212 |
| 2011-04-01 to 2011-06-30 | -9,006,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -17,421,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-04-01 to 2012-06-30 | 2,904,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 4,149,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | 108,025,000 | USD | 4212 |
| 2011-04-01 to 2011-06-30 | 2,735,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 5,555,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 2,569,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | 33,167,000 | USD | 4212 |
| 2011-01-01 to 2011-06-30 | 2,247,000 | USD | 181 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2000-12-19 to 2012-06-30 | 222,000 | USD | 4212 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | -2,219,000 | USD | 182 |
| 2000-12-19 to 2012-06-30 | 1,255,000 | USD | 4212 |
| 2011-01-01 to 2011-06-30 | -482,000 | USD | 181 |
Inspect the source
- Entity
- Alexza Pharmaceuticals Inc. / CIK 0001344413
- Captured
- SEC response SHA-256
acd343a5c5784dea4c635b4bd3fc9edc8adbee1c121312a435d6f2a752c538be
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001344413.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))